Article
Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research - 3 Apr 2023
Vasudev Naveen S, Scelo Ghislaine, Glennon Kate I, Wilson Michelle, Letourneau Louis, Eveleigh Robert, Nourbehesht Nazanin, Arseneault Madeleine, Paccard Antoine, Egevad Lars, Viksna Juris, Celms Edgars, Jackson Sharon M, Abedi-Ardekani Behnoush, Warren Anne Y, Selby Peter J, Trainor Sebastian, Kimuli Michael, Cartledge Jon, Soomro Naeem, Adeyoju Adebanji, Patel Poulam M, Wozniak Magdalena B, Holcatova Ivana, Brisuda Antonin, Janout Vladimir, Chanudet Estelle, Zaridze David, Moukeria Anush, Shangina Oxana, Foretova Lenka, Navratilova Marie, Mates Dana, Jinga Viorel, Bogdanovic Ljiljana, Kovacevic Bozidar, Cambon-Thomsen Anne, Bourque Guillaume, Brazma Alvis, Tost Jörg, Brennan Paul, Lathrop Mark, Riazalhosseini Yasser, Banks Rosamonde E
Abstract excerpt
PURPOSE: Patients with resected localized clear-cell renal cell carcinoma (ccRCC) remain at variable risk of recurrence. Incorporation of biomarkers may refine risk prediction and inform adjuvant treatment decisions. We explored the role of tumor genomics in this setting, leveraging the largest cohort to date of localized ccRCC tissues subjected to targeted gene sequencing. EXPERIMENTAL DESIGN: The somatic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.